[Prothanon eyedrops. 1. Results of experimental animal and orientative clinical studies].
D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D003231:Conjunctivitis / Q000188:drug therapy; D003315:Cornea / Q000187:drug effects*; D004342:Drug Hypersensitivity / Q000188:drug therapy; D004361:Drug Tolerance; D005123:Eye / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008012:Lidocaine / Q000494:pharmacology*; D009278:Naphazoline / Q000494:pharmacology; D009883:Ophthalmic Solutions; D011398:Promethazine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D000779:Anesthetics, Local; D009883:Ophthalmic Solutions; D008012:Lidocaine; D011398:Promethazine; D009278:Naphazoline
Uber Prothanon-Augentropfen. 1. Ergebnisse tierexperimenteller und orientierender klinischer Untersuchungen.